tradingkey.logo

Conmed Corp

CNMD
44.710USD
+0.760+1.73%
종가 11/11, 16:00ET시세는 15분 지연됩니다
1.38B시가총액
21.60P/E TTM

Conmed Corp

44.710
+0.760+1.73%

자세한 내용은 Conmed Corp 회사

CONMED Corporation is a medical technology company, which provides surgical devices and equipment for minimally invasive procedures. Its products are used by surgeons and other healthcare professionals in a variety of specialties including orthopedics, general surgery, gynecology, thoracic surgery, and gastroenterology. Its product lines consist of orthopedic surgery and general surgery. Orthopedic surgery consists of sports medicine and lower extremities instrumentation and implants, small bone, large bone, and specialty powered surgical instruments as well as imaging systems for use in minimally invasive surgery procedures and fees related to the sales representation, promotion, and marketing of sports medicine allograft tissue. General surgery consists of endo-mechanical instrumentation for minimally invasive laparoscopic and gastrointestinal procedures, smoke evacuation devices, a line of cardiac monitoring products as well as electrosurgical generators and related instruments.

Conmed Corp 정보

종목 코드 CNMD
회사 이름Conmed Corp
상장일Jul 23, 1987
CEOMr. Patrick J. (Pat) Beyer
직원 수3900
유형Ordinary Share
회계 연도 종료Jul 23
주소11311 Concept Boulevard
도시LARGO
증권 거래소NYSE Consolidated
국가United States of America
우편 번호33773
전화17272142974
웹사이트https://www.conmed.com/
종목 코드 CNMD
상장일Jul 23, 1987
CEOMr. Patrick J. (Pat) Beyer

Conmed Corp의 회사 임원진

이름
이름/직위
직위
주식 보유
변동
Mr. David M. Bronson
Mr. David M. Bronson
Independent Director
Independent Director
17.24K
+2.86%
Mr. Stephan Epinette
Mr. Stephan Epinette
Vice President and General Manager, International
Vice President and General Manager, International
15.51K
--
Mr. Patrick J. (Pat) Beyer
Mr. Patrick J. (Pat) Beyer
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
10.81K
--
Mr. Brian P. Concannon
Mr. Brian P. Concannon
Independent Director
Independent Director
10.12K
+4.97%
Ms. Barbara J. Schwarzentraub
Ms. Barbara J. Schwarzentraub
Independent Director
Independent Director
5.79K
+9.03%
Mr. Peter K Shagory
Mr. Peter K Shagory
Executive Vice President - Strategy and Corporate Development
Executive Vice President - Strategy and Corporate Development
3.90K
+5.01%
Ms. Hollie Foust
Ms. Hollie Foust
Executive Vice President, General Counsel and Corporate Secretary
Executive Vice President, General Counsel and Corporate Secretary
2.89K
--
Mr. Brent Lalomia
Mr. Brent Lalomia
Executive Vice President, Regulatory Affairs, Quality Assurance, Clinical Affairs, and Commercial Operations
Executive Vice President, Regulatory Affairs, Quality Assurance, Clinical Affairs, and Commercial Operations
1.13K
+18.20%
Mr. Kim Kelderman
Mr. Kim Kelderman
Independent Director
Independent Director
--
--
Mr. Richard Glaze
Mr. Richard Glaze
Chief Information Officer
Chief Information Officer
--
-100.00%
더 보기
이름
이름/직위
직위
주식 보유
변동
Mr. David M. Bronson
Mr. David M. Bronson
Independent Director
Independent Director
17.24K
+2.86%
Mr. Stephan Epinette
Mr. Stephan Epinette
Vice President and General Manager, International
Vice President and General Manager, International
15.51K
--
Mr. Patrick J. (Pat) Beyer
Mr. Patrick J. (Pat) Beyer
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
10.81K
--
Mr. Brian P. Concannon
Mr. Brian P. Concannon
Independent Director
Independent Director
10.12K
+4.97%
Ms. Barbara J. Schwarzentraub
Ms. Barbara J. Schwarzentraub
Independent Director
Independent Director
5.79K
+9.03%
Mr. Peter K Shagory
Mr. Peter K Shagory
Executive Vice President - Strategy and Corporate Development
Executive Vice President - Strategy and Corporate Development
3.90K
+5.01%

수익 분석

통화: USD마지막 업데이트: Mon, Oct 6
통화: USD마지막 업데이트: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
사업별USD
이름
수익
비율
General Surgery
201.61M
58.89%
Orthopedic Surgery
140.73M
41.11%
지역별USD
이름
수익
비율
United States
190.61M
55.68%
Europe & Middle East & Africa
63.92M
18.67%
Asia Pacific
42.07M
12.29%
Americas (excluding the United States)
31.88M
9.31%
사업별
지역별
사업별USD
이름
수익
비율
General Surgery
201.61M
58.89%
Orthopedic Surgery
140.73M
41.11%

주식 보유 통계

마지막 업데이트: Fri, Sep 26
마지막 업데이트: Fri, Sep 26
주주
주주 유형
주주
주주
비율
BlackRock Institutional Trust Company, N.A.
14.30%
The Vanguard Group, Inc.
11.63%
EARNEST Partners, LLC
9.14%
Fuller & Thaler Asset Management Inc.
5.62%
Capital Research Global Investors
5.41%
기타
53.90%
주주
주주
비율
BlackRock Institutional Trust Company, N.A.
14.30%
The Vanguard Group, Inc.
11.63%
EARNEST Partners, LLC
9.14%
Fuller & Thaler Asset Management Inc.
5.62%
Capital Research Global Investors
5.41%
기타
53.90%
주주 유형
주주
비율
Investment Advisor
65.04%
Investment Advisor/Hedge Fund
42.43%
Hedge Fund
4.59%
Research Firm
3.29%
Pension Fund
1.91%
Bank and Trust
0.68%
Individual Investor
0.59%
Sovereign Wealth Fund
0.06%
Venture Capital
0.05%

기관 주식 보유

마지막 업데이트: Wed, Oct 1
마지막 업데이트: Wed, Oct 1
보고 기간
기관 수
보유 주식
비율
변동
2025Q3
643
36.52M
117.92%
-5.77M
2025Q2
651
35.90M
115.99%
-5.38M
2025Q1
664
36.95M
119.42%
-4.31M
2024Q4
649
36.65M
118.59%
-2.95M
2024Q3
644
35.57M
115.39%
-3.57M
2024Q2
660
37.07M
120.35%
-1.36M
2024Q1
657
36.04M
117.06%
-2.92M
2023Q4
642
36.87M
119.89%
-1.61M
2023Q3
624
36.40M
118.42%
-2.31M
2023Q2
606
36.19M
118.37%
-3.41M
더 보기

주주 활동

이름
보유 주식
비율
변동
Chg %
날짜
BlackRock Institutional Trust Company, N.A.
4.43M
14.3%
-133.34K
-2.92%
Jun 30, 2025
The Vanguard Group, Inc.
3.54M
11.44%
+42.41K
+1.21%
Jun 30, 2025
EARNEST Partners, LLC
2.83M
9.14%
+30.22K
+1.08%
Jun 30, 2025
Fuller & Thaler Asset Management Inc.
1.74M
5.62%
+566.60K
+48.26%
Jun 30, 2025
Capital Research Global Investors
1.68M
5.41%
+2.76K
+0.16%
Jun 30, 2025
Managed Account Advisors LLC
1.38M
4.47%
+103.77K
+8.11%
Jun 30, 2025
State Street Investment Management (US)
1.29M
4.18%
-8.83K
-0.68%
Jun 30, 2025
Westwood Management Corp. (Texas)
1.24M
4%
-484.00
-0.04%
Jun 30, 2025
Dimensional Fund Advisors, L.P.
1.08M
3.5%
+184.21K
+20.50%
Jun 30, 2025
Macquarie Investment Management
969.64K
3.13%
+16.21K
+1.70%
Jun 30, 2025
더 보기

관련 ETF

마지막 업데이트: Thu, Nov 6
마지막 업데이트: Thu, Nov 6
이름
비율
SPDR S&P Health Care Equipment ETF
1.46%
ROBO Global Healthcare Technology & Innovation ETF
1.14%
Invesco S&P SmallCap Health Care ETF
0.93%
Harbor Human Capital Factor US Small Cap ETF
0.59%
VictoryShares Small Cap Free Cash Flow ETF
0.35%
iShares US Small Cap Value Factor ETF
0.34%
First Trust Small Cap Value AlphaDEX Fund
0.3%
WisdomTree US SmallCap Quality Dividend Growth
0.26%
Lattice Hartford Multifactor Small Cap ETF
0.23%
Royce Quant Small-Cap Quality Value ETF
0.23%
더 보기
SPDR S&P Health Care Equipment ETF
비율1.46%
ROBO Global Healthcare Technology & Innovation ETF
비율1.14%
Invesco S&P SmallCap Health Care ETF
비율0.93%
Harbor Human Capital Factor US Small Cap ETF
비율0.59%
VictoryShares Small Cap Free Cash Flow ETF
비율0.35%
iShares US Small Cap Value Factor ETF
비율0.34%
First Trust Small Cap Value AlphaDEX Fund
비율0.3%
WisdomTree US SmallCap Quality Dividend Growth
비율0.26%
Lattice Hartford Multifactor Small Cap ETF
비율0.23%
Royce Quant Small-Cap Quality Value ETF
비율0.23%

주식 배당금

지난 5년 동안 총 119.19M USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
Feb 25, 2025
CNMD.NB Interim Cash Dividend of gross USD 0.2 paid on Apr 04, 2025 going ex on Mar 14, 2025
Mar 14, 2025
Apr 04, 2025
Mar 14, 2025
Dec 10, 2024
CNMD.NB Interim Cash Dividend of gross USD 0.2 paid on Jan 03, 2025 going ex on Dec 20, 2024
Dec 20, 2024
Jan 03, 2025
Dec 20, 2024
Aug 09, 2024
CNMD.NB Final Cash Dividend of gross USD 0.2 paid on Oct 04, 2024 going ex on Sep 16, 2024
Sep 16, 2024
Oct 04, 2024
Sep 16, 2024
May 22, 2024
CNMD.NB Interim Cash Dividend of gross USD 0.2 paid on Jul 05, 2024 going ex on Jun 14, 2024
Jun 14, 2024
Jul 05, 2024
Jun 14, 2024
Feb 26, 2024
CNMD.NB Interim Cash Dividend of gross USD 0.2 paid on Apr 05, 2024 going ex on Mar 14, 2024
Mar 15, 2024
Apr 05, 2024
Mar 14, 2024
Dec 05, 2023
CNMD.NB Interim Cash Dividend of gross USD 0.2 paid on Jan 05, 2024 going ex on Dec 15, 2023
Dec 18, 2023
Jan 05, 2024
Dec 15, 2023
Aug 10, 2023
CNMD.NB Final Cash Dividend of gross USD 0.2 paid on Oct 05, 2023 going ex on Sep 14, 2023
Sep 15, 2023
Oct 05, 2023
Sep 14, 2023
May 24, 2023
CNMD.NB Interim Cash Dividend of gross USD 0.2 paid on Jul 05, 2023 going ex on Jun 14, 2023
Jun 15, 2023
Jul 05, 2023
Jun 14, 2023
Feb 27, 2023
CNMD.NB Interim Cash Dividend of gross USD 0.2 paid on Apr 05, 2023 going ex on Mar 14, 2023
Mar 15, 2023
Apr 05, 2023
Mar 14, 2023
Dec 05, 2022
CNMD.NB Interim Cash Dividend of gross USD 0.2 paid on Jan 05, 2023 going ex on Dec 15, 2022
Dec 16, 2022
Jan 05, 2023
Dec 15, 2022
더 보기

주식 분할

날짜
유형
비율
데이터 없음
날짜
유형
비율
데이터 없음
tradingkey.logo
당일 거래 데이터는 Refinitiv에서 제공하며, 이용 약관이 적용됩니다. 역사적 및 현재 종가 데이터는 Refinitiv에서 제공합니다. 모든 시세는 현지 거래소 시간 기준입니다. 미국 주식 시세의 실시간 마지막 거래 데이터는 Nasdaq을 통해 보고된 거래만 반영됩니다. 당일 거래 데이터는 최소 15분 지연되거나 거래소 요구 사항에 따라 다를 수 있습니다.
* 참고자료, 분석 및 트레이딩 전략은 제3자 제공업체인 Trading Central에서 제공하며, 분석가의 독립적인 평가와 판단에 기반한 시각으로, 투자자의 투자 목표와 재정 상황은 고려되지 않습니다.
위험 경고: 저희 웹사이트와 모바일 앱은 특정 투자 상품에 대한 일반적인 정보만을 제공합니다. Finsights는 재정적 조언이나 투자 상품에 대한 추천을 제공하지 않으며, 이러한 정보 제공이 Finsights가 금융 조언이나 추천을 제공하는 것으로 해석되어서는 안 됩니다.
투자 상품은 투자 원금 손실을 포함한 상당한 투자 위험에 노출되어 있으며, 모든 사람에게 적합하지 않을 수 있습니다. 투자 상품의 과거 성과는 미래 성과를 보장하지 않습니다.
Finsights는 제3자 광고주나 제휴사가 저희 웹사이트나 모바일 앱 또는 그 일부에 광고를 게재하거나 전달할 수 있도록 허용할 수 있으며, 사용자가 광고와 상호작용하는 방식에 따라 이들로부터 보상을 받을 수 있습니다.
© 저작권: FINSIGHTS MEDIA PTE. LTD. 모든 권리 보유
KeyAI